These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21554436)

  • 41. Subcutaneous injection immunotherapy for optimal effectiveness.
    Nelson HS
    Immunol Allergy Clin North Am; 2011 May; 31(2):211-26, viii. PubMed ID: 21530815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'.
    Calderón MA; Larenas D; Kleine-Tebbe J; Jacobsen L; Passalacqua G; Eng PA; Varga EM; Valovirta E; Moreno C; Malling HJ; Alvarez-Cuesta E; Durham S; Demoly P
    Allergy; 2011 Oct; 66(10):1345-59. PubMed ID: 21707645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L; Wallace D
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Food allergy to apple and specific immunotherapy with birch pollen.
    Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
    Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
    Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
    Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Vaccine; 2006 Nov; 24(47-48):6990-3. PubMed ID: 17011086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sublingual immunotherapy.
    Esch RE
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):260-4. PubMed ID: 18475082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood.
    Eng PA; Borer-Reinhold M; Heijnen IA; Gnehm HP
    Allergy; 2006 Feb; 61(2):198-201. PubMed ID: 16409196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance.
    Jakobsen CG; Bodtger U; Poulsen LK; Roggen EL
    Clin Exp Allergy; 2005 Feb; 35(2):193-8. PubMed ID: 15725191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
    Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
    Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Allergen specific immunotherapy: review of new perspectives].
    Gaillard J; Bart PA; Leimgruber A; Spertini F
    Rev Med Suisse; 2011 Apr; 7(291):850-5. PubMed ID: 21598725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific immunotherapy in children.
    Bufe A; Roberts G
    Clin Exp Allergy; 2011 Sep; 41(9):1256-62. PubMed ID: 21518041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of subcutaneous allergen immunotherapy.
    Soyer OU; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune tolerance in allergy.
    Akdis M
    Curr Opin Immunol; 2009 Dec; 21(6):700-7. PubMed ID: 19700272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
    Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.